Dai Hayward of CellAura Technologies explains how binding assays have held onto their dominance.
Klaus Weinberger of BIOCRATES Life Sciences AG explains the potential of metabolomics to revolutionize diverse areas of life.
When it comes to real-time PCR in drug discovery, Richard Kurtz believes that MIQE guidelines will help create a clear path to better results.
Advanced animal model generation and production technologies can change the game for investigators, accelerating drug discovery and optimizing research success.
For a long time the dogma existed that there are no in vitro alternatives for reprotoxicity studies. Luckily, this holds no longer true! By EggCentris